A comparison between Nimbadi Ghana Vati and Phalatikadi Ghana Vati in Madhumeha (Diabetes mellitus 2).

A COMPARATIVE STUDY TO EVALUATE THE EFFEICACY OF NIMBADI GHANA VATI AND PHALATRIKADI GHANA VATI IN THE MANAGEMENT OF MADHUMEHA (TYPE 2 DIABETES MELLITUS)- A RANDOMISED CONTROLLED CLINICAL TRIAL.

Status

Active, not recruiting

Phases

Phase 2Phase 3

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2023/04/051750

Enrollment

Registered

2023-04-19

Start date

Unknown

Completion date

Unknown

Last updated

2023-05-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: E119- Type 2 diabetes mellitus without complications

Interventions

None listed

Eligibility

Inclusion criteria

Inclusion criteria: 1.Either gender in the age group 30-60 yrs with classical signs and symptoms of Madhumeha. 2.Patients fulfilling the general diagnostic criteria for diabetes mellitus.(as per diabetic protocol by MOA/AIIA). 3.RBS more than or equal to 200 to 450 mg/dl. 4.FBS more than or equal to 126 to 350 mg/dl. 5.PPBS more than or equal to 200 to 450 mg/dl. 6.Glycosylated haemoglobin more than or equal to 6.5% to 15%. 7.Newly/early diagnosed cases to be included as per following criteria: - patients accidentally diagnosed in routine check-up or when appeared with other complaints in the hospital. - early diagnosed diabetic patients ( - patients who used to take conventional medicines and stopped taking them for 3 months & were willing to take Ayurvedic Medicines.

Exclusion criteria

Exclusion criteria: 1.Patients having insulin dependent DM(type1) and receiving OHA. 2.Age 60yrs, pregnant women and lactating mothers. 3.Excessive blood sugar:FBS >350mg/dl and PPBS >450mg/dl. 4.Emergency conditions in cases of DM, chronic complications and patients with other diseases such as chronic liver diseases, thyroid disorders, hypertension, CKD, heart diseases etc. 5.Patients who were not fit for yoga.

Design outcomes

Primary

Measure	Time frame
Reduction in the level of Glycosylated haemoglobin (HbA1c). Timepoint: (DAY-0)(DAY-7)(DAY-14)(DAY-30)(DAY-45)(DAY-60)(DAY-75)(DAY-90)	—

Secondary

Measure	Time frame
1.Improvement in the signs and symptoms of Madhumeha after 90days. 2.Reduction in the level of FBS & PPBS at 30th,60th and 90th day of the study . 3.Improvement in the quality and quantity of urine after 90 days. 4. Improvement in the quality of life after a period of 90days. Timepoint: (DAY-0)(DAY-7)(DAY-14)(DAY-30)(DAY-45)(DAY-60)(DAY-75)(DAY-90)	—

Countries

India

Contacts

Public ContactDr Raja Ram Mahto

All India Institute Of Ayurveda, Gautampuri, Sarita Vihar ,NEW Delhi-110076

karishmarabha57@gmail.com8368521535

Outcome results